Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 229

1.

Linezolid does not increase the risk of thrombocytopenia in patients with nosocomial pneumonia: comparative analysis of linezolid and vancomycin use.

Nasraway SA, Shorr AF, Kuter DJ, O'Grady N, Le VH, Cammarata SK.

Clin Infect Dis. 2003 Dec 15;37(12):1609-16. Epub 2003 Nov 20.

PMID:
14689341
2.

Linezolid versus vancomycin or teicoplanin for nosocomial pneumonia: a systematic review and meta-analysis.

Kalil AC, Murthy MH, Hermsen ED, Neto FK, Sun J, Rupp ME.

Crit Care Med. 2010 Sep;38(9):1802-8. doi: 10.1097/CCM.0b013e3181eb3b96. Review.

PMID:
20639754
3.

Continuation of a randomized, double-blind, multicenter study of linezolid versus vancomycin in the treatment of patients with nosocomial pneumonia.

Wunderink RG, Cammarata SK, Oliphant TH, Kollef MH; Linezolid Nosocomial Pneumonia Study Group.

Clin Ther. 2003 Mar;25(3):980-92.

PMID:
12852712
4.

Similar hematologic effects of long-term linezolid and vancomycin therapy in a prospective observational study of patients with orthopedic infections.

Rao N, Ziran BH, Wagener MM, Santa ER, Yu VL.

Clin Infect Dis. 2004 Apr 15;38(8):1058-64. Epub 2004 Mar 26.

PMID:
15095207
5.

Hematologic effects of linezolid in young children.

Meissner HC, Townsend T, Wenman W, Kaplan SL, Morfin MR, Edge-Padbury B, Naberhuis-Stehouwer S, Bruss JB.

Pediatr Infect Dis J. 2003 Sep;22(9 Suppl):S186-92.

PMID:
14520145
6.

Linezolid versus vancomycin for the treatment of infections caused by methicillin-resistant Staphylococcus aureus in Japan.

Kohno S, Yamaguchi K, Aikawa N, Sumiyama Y, Odagiri S, Aoki N, Niki Y, Watanabe S, Furue M, Ito T, Croos-Dabrera R, Tack KJ.

J Antimicrob Chemother. 2007 Dec;60(6):1361-9. Epub 2007 Oct 3.

PMID:
17913720
7.

Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: a randomized, double-blind, multicenter study.

Rubinstein E, Cammarata S, Oliphant T, Wunderink R; Linezolid Nosocomial Pneumonia Study Group.

Clin Infect Dis. 2001 Feb 1;32(3):402-12. Epub 2001 Jan 26.

PMID:
11170948
8.

A comparative evaluation of adverse platelet outcomes among Veterans' Affairs patients receiving linezolid or vancomycin.

Patel N, VanDeWall H, Tristani L, Rivera A, Woo B, Dihmess A, Li HK, Smith R, Lodise TP.

J Antimicrob Chemother. 2012 Mar;67(3):727-35. doi: 10.1093/jac/dkr522. Epub 2011 Dec 15.

PMID:
22174041
9.

Linezolid for the treatment of children with bacteremia or nosocomial pneumonia caused by resistant gram-positive bacterial pathogens.

Jantausch BA, Deville J, Adler S, Morfin MR, Lopez P, Edge-Padbury B, Naberhuis-Stehouwer S, Bruss JB.

Pediatr Infect Dis J. 2003 Sep;22(9 Suppl):S164-71.

PMID:
14520142
10.

Linezolid for the treatment of infections caused by Gram-positive pathogens in China.

Lin DF, Zhang YY, Wu JF, Wang F, Zheng JC, Miao JZ, Zheng LY, Sheng RY, Zhou X, Shen HH, Ijzerman MM, Croos-Dabrera RV, Sheng W.

Int J Antimicrob Agents. 2008 Sep;32(3):241-9. doi: 10.1016/j.ijantimicag.2008.04.004. Epub 2008 Jul 16.

PMID:
18635341
11.

Efficacy and safety of linezolid in liver transplant patients.

Radunz S, Juntermanns B, Kaiser GM, Treckmann J, Mathe Z, Paul A, Saner FH.

Transpl Infect Dis. 2011 Aug;13(4):353-8. doi: 10.1111/j.1399-3062.2011.00617.x. Epub 2011 Feb 28.

PMID:
21355969
12.

Retrospective cohort chart review study of factors associated with the development of thrombocytopenia in adult Japanese patients who received intravenous linezolid therapy.

Niwa T, Suzuki A, Sakakibara S, Kasahara S, Yasuda M, Fukao A, Matsuura K, Goto C, Murakami N, Itoh Y.

Clin Ther. 2009 Oct;31(10):2126-33. doi: 10.1016/j.clinthera.2009.10.017.

PMID:
19922883
13.

Efficacy and safety of linezolid compared with vancomycin in a randomized, double-blind study of febrile neutropenic patients with cancer.

Jaksic B, Martinelli G, Perez-Oteyza J, Hartman CS, Leonard LB, Tack KJ.

Clin Infect Dis. 2006 Mar 1;42(5):597-607. Epub 2006 Jan 25.

PMID:
16447103
14.

Linezolid versus vancomycin for Staphylococcus aureus bacteraemia: pooled analysis of randomized studies.

Shorr AF, Kunkel MJ, Kollef M.

J Antimicrob Chemother. 2005 Nov;56(5):923-9. Epub 2005 Sep 29.

PMID:
16195255
15.

Thrombocytopenia associated with linezolid therapy.

Attassi K, Hershberger E, Alam R, Zervos MJ.

Clin Infect Dis. 2002 Mar 1;34(5):695-8. Epub 2002 Jan 17.

PMID:
11803505
16.

Linezolid versus vancomycin for the treatment of gram-positive bacterial infections: meta-analysis of randomised controlled trials.

Beibei L, Yun C, Mengli C, Nan B, Xuhong Y, Rui W.

Int J Antimicrob Agents. 2010 Jan;35(1):3-12. doi: 10.1016/j.ijantimicag.2009.09.013. Epub 2009 Nov 8. Review.

PMID:
19900794
17.

Complicated skin and skin-structure infections and catheter-related bloodstream infections: noninferiority of linezolid in a phase 3 study.

Wilcox MH, Tack KJ, Bouza E, Herr DL, Ruf BR, Ijzerman MM, Croos-Dabrera RV, Kunkel MJ, Knirsch C.

Clin Infect Dis. 2009 Jan 15;48(2):203-12. doi: 10.1086/595686.

PMID:
19072714
18.

Comparison of length of hospital stay for patients with known or suspected methicillin-resistant Staphylococcus species infections treated with linezolid or vancomycin: a randomized, multicenter trial.

Li Z, Willke RJ, Pinto LA, Rittenhouse BE, Rybak MJ, Pleil AM, Crouch CW, Hafkin B, Glick HA.

Pharmacotherapy. 2001 Mar;21(3):263-74.

PMID:
11256381
19.

Probable linezolid-induced thrombocytopenia in a patient with vancomycin-resistant enterococci.

Poulakos MN, Grace Y, Coakley C.

J Pharm Pract. 2012 Dec;25(6):615-8. doi: 10.1177/0897190012442720. Epub 2012 Apr 27.

PMID:
22544622
20.

Linezolid versus vancomycin or teicoplanin for nosocomial pneumonia: meta-analysis of randomised controlled trials.

Jiang H, Tang RN, Wang J.

Eur J Clin Microbiol Infect Dis. 2013 Sep;32(9):1121-8. doi: 10.1007/s10096-013-1867-z. Epub 2013 Apr 10. Review.

PMID:
23568605

Supplemental Content

Support Center